Jun 19, 2026
Medical device contract manufacturing has evolved into one of the most dynamic and strategically critical segments of the global healthcare supply chain. As original equipment manufacturers (OEMs) and innovators face mounting pressure to accelerate time-to-market, reduce capital expenditure, and navigate an increas...
Read More...
Nov 22, 2018
Cambrex takes over Avista in USD 250 Million agreement Cambrex, life sciences company, is taking over Avista Pharma Solutions with a deal of USD 250 million to become a leading contract development and manufacturing organization (CDMO). The agreement includes the early-stage drug development and manufacturing capabi...
Read More...
Intratumoral Cancer Therapy: A Potential Weapon To Fight the Battle Against Cancer
Aug 05, 2026
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Newsletter/Whitepaper